标题
Hypertension pharmacogenomics: in search of personalized treatment approaches
作者
关键词
-
出版物
Nature Reviews Nephrology
Volume 12, Issue 2, Pages 110-122
出版商
Springer Nature
发表日期
2015-11-23
DOI
10.1038/nrneph.2015.176
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association of Angiotensinogen (M235T) Gene Polymorphism with Blood Pressure Lowering Response to Angiotensin Converting Enzyme Inhibitor (Enalapril)
- (2016) Kamna Srivastava et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype
- (2015) Nihal El Rouby et al. CURRENT HYPERTENSION REPORTS
- NEDD4-2 and salt-sensitive hypertension
- (2015) Federica Rizzo et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives
- (2015) Martina Chittani et al. JOURNAL OF HYPERTENSION
- Pharmacogenomics of Hypertension: A Genome-Wide, Placebo-Controlled Cross-Over Study, Using Four Classes of Antihypertensive Drugs
- (2015) T. P. Hiltunen et al. Journal of the American Heart Association
- Is a Diabetes Mellitus-Linked Amino Acid Signature Associated With -Blocker-Induced Impaired Fasting Glucose?
- (2014) R. M. Cooper-DeHoff et al. Circulation-Cardiovascular Genetics
- G-Protein Receptor Kinase 4 Polymorphism and Response to Antihypertensive Therapy
- (2014) A. M. Muskalla et al. CLINICAL CHEMISTRY
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of Common Polymorphisms in β1-adrenergic Receptor With Antihypertensive Response to Carvedilol
- (2014) Dayong Si et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors
- (2014) Huimin Yu et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Blood pressure lowering and cardiovascular risk – Authors' reply
- (2014) Johan Sundström et al. LANCET
- PCSK9 inhibitors for treating familial hypercholesterolaemia
- (2014) Hiroshi Mabuchi et al. Nature Reviews Endocrinology
- Emerging Roles for Pharmacists in Clinical Implementation of Pharmacogenomics
- (2014) Aniwaa Owusu-Obeng et al. PHARMACOTHERAPY
- Multilocus Genetic Risk Score Associates With Ischemic Stroke in Case–Control and Prospective Cohort Studies
- (2014) Rainer Malik et al. STROKE
- Twelve–Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke
- (2014) Hayato Tada et al. STROKE
- The Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension
- (2013) G. L. Schwartz et al. AMERICAN JOURNAL OF HYPERTENSION
- Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction
- (2013) Andrea Ganna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Loci influencing blood pressure identified using a cardiovascular gene-centric array
- (2013) Santhi K. Ganesh, Vinicius Tragante, Wei Guo, Yiran Guo, Matthew B. Lanktree, Erin N. Smith, Toby Johnson, Berta Almoguera Castillo, John Barnard, Jens Baumert, Yen-Pei Christy Chang, Clara C. Elbers, Martin Farrall, Mary E. Fischer, Nora Franceschini, Tom R. Gaunt, Johannes M.I.H. Gho, Christian Gieger, Yan Gong, Aaron Isaacs, Marcus E. Kleber, Irene Mateo Leach, Caitrin W. McDonough, Matthijs F.L. Meijs, Olle Mellander, Cliona M. Molony, Ilja M. Nolte, Sandosh Padmanabhan, Tom S. Price, Ramakrishnan Rajagopalan, Jonathan Shaffer, Sonia Shah, Haiqing Shen, Nicole Soranzo, Peter J. van der Most, Erik P.A. Van Iperen, Jessic A. Van Setten, Judith M. Vonk, Li Zhang, Amber L. Beitelshees, Gerald S. Berenson, Deepak L. Bhatt, Jolanda M.A. Boer, Eric Boerwinkle, Ben Burkley, Amber Burt, Aravinda Chakravarti, Wei Chen, Rhonda M. Cooper-DeHoff, Sean P. Curtis, Albert Dreisbach, David Duggan, Georg B. Ehret, Richard R. Fabsitz, Myriam Fornage, Ervin Fox, Clement E. Furlong, Ron T. Gansevoort, Marten H. Hofker, G. Kees Hovingh, Susan A. Kirkland, Kandice Kottke-Marchant, Abdullah Kutlar, Andrea Z. LaCroix, Taimour Y. Langaee, Yun R. Li, Honghuang Lin, Kiang Liu, Steffi Maiwald, Rainer Malik, Gurunathan Murugesan, Christopher Newton-Cheh, Jeffery R. O'Connell, N. Charlotte Onland-Moret, Willem H. Ouwehand et al. HUMAN MOLECULAR GENETICS
- A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals
- (2013) Aki S. Havulinna et al. HYPERTENSION
- Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12 , A1BG , and the Selectin Region and Cardiovascular Outcomes
- (2013) Caitrin W. McDonough et al. HYPERTENSION
- Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide
- (2013) Stephen T. Turner et al. HYPERTENSION
- Effects of ACE and ADD1 gene polymorphisms on blood pressure response to hydrochlorothiazide: a meta-analysis
- (2013) Hye Duck Choi et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics
- (2013) Caitrin W. McDonough et al. JOURNAL OF HYPERTENSION
- Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death
- (2013) Jonas Dahlberg et al. JOURNAL OF HYPERTENSION
- S49G and R389G polymorphisms of the β1-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways
- (2013) Fan Zhang et al. PHYSIOLOGICAL GENOMICS
- Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
- (2013) William R. Wikoff et al. PLoS One
- Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta 1 389 Arg/Gly Adrenergic Receptor Polymorphism
- (2013) Ryan G. Aleong et al. JACC-Heart Failure
- Assessment of the value of a genetic risk score in improving the estimation of coronary risk
- (2012) Carla Lluis-Ganella et al. ATHEROSCLEROSIS
- Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension
- (2012) Qiuping Gu et al. CIRCULATION
- Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure
- (2012) Ryan G. Aleong et al. Circulation-Arrhythmia and Electrophysiology
- G protein receptor kinase 4 polymorphisms
- (2012) Alexander G. Vandell et al. HYPERTENSION
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Stephen S Lim et al. LANCET
- Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
- (2012) J D Duarte et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
- (2012) Xue Zhang et al. PLoS One
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals
- (2011) Andrew D. Johnson et al. HYPERTENSION
- Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
- (2011) Louise V Wain et al. NATURE GENETICS
- Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy
- (2011) Elvin Tyrone Price et al. Pharmacogenetics and Genomics
- Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
- (2011) Rikki M. Tanner et al. PLoS One
- Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
- (2010) S. T. Turner et al. AMERICAN JOURNAL OF HYPERTENSION
- US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
- (2010) Brent M. Egan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Common genetic variations of the renin–angiotensin–aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension
- (2010) Tuula Hannila-Handelberg et al. JOURNAL OF HYPERTENSION
- A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients
- (2010) Patrik Svensson-Färbom et al. JOURNAL OF HYPERTENSION
- Genetic variation in the renin—angiotensin system, use of renin—angiotensin system inhibitors and the risk of myocardial infarction
- (2010) Anke-Hilse Maitland-van der Zee et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study
- (2010) Børge G. Nordestgaard et al. Pharmacogenetics and Genomics
- G-Protein-Coupled Receptor Kinase 4 Polymorphisms and Blood Pressure Response to Metoprolol Among African Americans: Sex-Specificity and Interactions
- (2009) V. Bhatnagar et al. AMERICAN JOURNAL OF HYPERTENSION
- Hydrochlorothiazide and Atenolol Combination Antihypertensive Therapy: Effects of Drug Initiation Order
- (2009) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study
- (2009) Georg B Ehret et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A Functional Variant of NEDD4L Is Associated With Hypertension, Antihypertensive Response, and Orthostatic Hypotension
- (2009) Fang Luo et al. HYPERTENSION
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)
- (2008) Tobias Gerhard et al. AMERICAN HEART JOURNAL
- 1- and 2-Adrenergic Receptor Gene Variation, -Blocker Use and Risk of Myocardial Infarction and Stroke
- (2008) R. N. Lemaitre et al. AMERICAN JOURNAL OF HYPERTENSION
- β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
- (2008) MA Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic
- (2008) Stephen T. Turner et al. HYPERTENSION
- Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension
- (2008) Amy I. Lynch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interaction between the Gly460Trp α-adducin gene variant and diuretics on the risk of myocardial infarction
- (2008) Diane BMA van Wieren-de Wijer et al. JOURNAL OF HYPERTENSION
- Global burden of blood-pressure-related disease, 2001
- (2008) Carlene MM Lawes et al. LANCET
- Treatment of Hypertension in Patients 80 Years of Age or Older
- (2008) Nigel S. Beckett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke
- (2008) H Schelleman et al. PHARMACOGENOMICS JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now